An overview of our treatment centers follows with links to more comprehensive information at our sites of care.

Hematologic Malignancies

Patients with hematologic malignancies (cancers of the blood or blood-forming tissues), such as leukemia, Hodgkin's and non-Hodgkin's lymphomas, AIDS-related malignancies, multiple myeloma, myelodysplasia and myeloproliferative disorders, have access to the latest therapeutic approaches, including investigational treatments, through the hematologic malignancies treatment centers.

Available treatments include standard outpatient and intensive inpatient chemotherapy, high-dose myeloablative therapy with stem-cell support (autologous, allogeneic, or unrelated donor bone marrow transplantation), radiation therapy, and new immune-based treatments.

A multidisciplinary team of specialists participate in patients' care. This team includes medical oncologists, radiation oncologists, hematopathologists, infectious diseases specialists, and oral surgeons, in addition to dietitians and social workers. Patients and family members have access to support groups and educational programs, complementary therapies, and low-cost housing.

Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center
This is a general page in which the user can find the specific program. If you want to direct the user to the specific programs the individual urls are as follows:
Center for Leukemia
Center for Lymphoma